← Leaderboards
John G Kuhn
University Of Texas Hlth Sci Ctr San Ant
$1,375,397
Attributed
$1,375,397
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $183.8K · FY2005–08$200K$150K$100K$50K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$1,375,397 · 1
By mechanism
U01$1,375,397 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Daniel D Von Hoff$23,238,156
- Eric K Rowinsky$9,623,858
- Ralph A Defronzo$27,122,787
- George B Kudolo$2,138,243
- Jean X Jiang$13,187,441
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsAnalytical MethodNeoplasm /Cancer ChemotherapyNeoplasm /Cancer PharmacologyHigh Performance Liquid ChromatographyCentral Nervous System NeoplasmsCerebrospinal FluidMethod DevelopmentOral AdministrationAntineoplasticsPharmacokineticsBody FluidsClearance RateClinical ResearchExcretionGas ChromatographyHuman TissueTemozolomidePaclitaxelBiologicalChromatography, High Pressure LiquidDrug KineticsBaseAntineoplastic Agents
Grant awards (10)
Phase I/I I PK/PD Studies of Agents for CNS Malignancies (NABTC PK Center)$183,840
U01 · FY2008 · CA · contact PI
Phase I/I I PK/PD Studies of Agents for CNS Malignancies (NABTC PK Center)$177,174
U01 · FY2007 · CA · contact PI
Phase I/II PK/PD Studies of Agents for CNS Malignancies*$181,986
U01 · FY2006 · CA · contact PI
Phase I/II PK/PD Studies of Agents for CNS Malignancies*$180,949
U01 · FY2005 · CA
Phase I/II PK/PD Studies of Agents for CNS Malignancies*$175,680
U01 · FY2004 · CA
PHASE I/II PK/PD STUDIES OF AGENTS FOR CNS MALIGNANCIES$124,537
U01 · FY2003 · CA
PHASE I/II PK/PD STUDIES OF AGENTS FOR CNS MALIGNANCIES$120,627
U01 · FY2002 · CA
PHASE I/II PK/PD STUDIES OF AGENTS FOR CNS MALIGNANCIES$112,910
U01 · FY2001 · CA
PHASE I/II PK/PD STUDIES OF AGENTS FOR CNS MALIGNANCIES$102,849
U01 · FY2000 · CA
PHASE I/II PK/PD STUDIES OF AGENTS FOR CNS MALIGNANCIES$14,845
U01 · FY2000 · CA